Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction
Ingredients Container: 60 vegetarian capsules Serving Size: 1 capsule Servings per Container: 60 Form: Vegetarian capsules Ingredients Content in a portion in 100 g % RDI Other ingredients High and low viscosity hydroxypropyl methylcellulose, Magnesium Citrate, and Calcium Laurate (Time-Sorb), Hypromellose (derived from cellulose) capsule, Leucine, Silicon Dioxide.*Glutathione complexed with Time-Sorb, a time-release matrix
It usually results in more weight loss than semaglutide and can have similar effects on blood pressure and cardiovascular health as semaglutide
Switching from Semaglutide to Tirzepatide Reasons for Making the Switch Several reasons might motivate a patient to switch from Semaglutide to Tirzepatide: Weight Loss Plateau : If youve been using Semaglutide for weight loss but feel like youve hit a plateau, Tirzepatide could offer a new chance for further weight reduction
US$ 27.85
US$ 21.28
US$ 27.96
